Quinazoline-based human phosphodiesterase 5 inhibitors exhibited a selective vasorelaxant effect on rat isolated pulmonary arteries involving NO-sGC-cGMP pathway and calcium inhibitory effects-Reference-Cited by-同舟云学术

Quinazoline-based human phosphodiesterase 5 inhibitors exhibited a selective vasorelaxant effect on rat isolated pulmonary arteries involving NO-sGC-cGMP pathway and calcium inhibitory effects

Published:2022-12 Issue: Volume:147 Page:107111
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Chatturong Usana,Martin Hélène,Totoson Perle,Ingkaninan Kornkanok,Temkitthawon Prapapan,Sermsenaphorn Saharat,Somarin Thanachon,Konsue Adchatawut,Gleeson M. Paul,Demougeot Céline,Chootip Krongkarn

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference29 articles.

1. Right heart failure in pulmonary hypertension: diagnosis and new perspectives on vascular and direct right ventricular treatment;Tello;Br. J. Pharmacol.,2021

2. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases: highlights from basic research to therapy;Huertas;Eur. Respir. J.,2018

3. Current and future treatments of pulmonary arterial hypertension;Sommer;Br. J. Pharmacol.,2021

4. PDE5 inhibitors–pharmacology and clinical applications 20 years after sildenafil discovery;Andersson;Br. J. Pharmacol.,2018

5. Pulmonary hypertension in chronic obstructive pulmonary disease;Gredic;Br. J. Pharmacol.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06

2. The new quinazoline derivative (N-methyl-N-[(thiophen-2-yl)methyl]quinazoline-2,4-diamine) vasodilates isolated mesenteric arteries through endothelium-independent mechanisms and has acute hypotensive effects in Wistar rats;European Journal of Pharmacology;2023-08